Speaker

Madeline Pe, PhD is the Head of the Quality of Life Department at the European Organisation for Research and Treatment of Cancer (EORTC). She leads a team that provides advice and methodological guidance for the inclusion of QOL endpoints in EORTC trials. She ensures that support is provided to the EORTC Quality of Life Group network for the development of the QOL measures and other research activities. Dr. Pe’s expertise is on statistical and methodological research for participant/patient-reported outcomes. She is the academic and scientific lead for SISAQOL-IMI Consortium, which is an international, multi-stakeholder consortium aiming to develop consensus recommendations for the design, analysis and interpretation of patient-reported outcomes and quality of life endpoints in cancer clinical trials. She is a past member of the International Advisory Board for the Lancet Oncology and collaborates with different international stakeholder groups to promote the inclusion of QoL into their cancer research programs.